Odetiglucan

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameOdetiglucan
Drug Alias NameB-glucan PGGBTH-1677PGG glucanSoluble beta glucanImprime PGG +[6] 
ClassificationBiologics
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSkin MelanomaCarcinoma, Non-Small-Cell LungColorectal Neoplasms +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto RicoPhilippines +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiothera Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of PennsylvaniaMerck Sharp & Dohme LLCHiberCell Inc
Inactive CompaniesDana-Farber Cancer InstituteNational Cancer InstituteMayo Clinic
Active IndicationsColorectal NeoplasmsBreast NeoplasmsCarcinoma, Pancreatic Ductal
Inactive IndicationsSkin MelanomaCarcinoma, Non-Small-Cell LungTriple Negative Breast Neoplasms +[7] 

Other Information

ATC CodeN/A
Related LinksN/A